On January 31, the Aetna Foundation announced 10 community health programs nationwide that are receiving their newly-launched “Spotlight Award.” The award is part of the
Healthiest Cities & Counties Challenge, an initiative launched in 2016 that supports 50 small-to-midsize cities and counties that are implementing innovative solutions to pressing public health issues in their communities. Along with the American Public Health Association (APHA) and the National Association of Counties (NACo), the Aetna Foundation selected these 50 programs because of their ability to tackle social determinants of health (SDoH) that frequently lead to chronic health issues.
Read More
|
|
|
|
Duke GHIC Wins Two New Awards Totaling over $13 Million to Enhance Global Efforts to Save Lives At Birth
|
Several Duke University organizations, led by the
Duke Global Health Innovation Center (GHIC)
, are partnering with the US Agency for International Development (USAID) and other global development organizations to evaluate the
Saving Lives at Birth
program and help organizations scale up maternal and newborn health innovations more quickly and sustainably.
Read More
|
|
Tell us how we are doing!
The Duke-Margolis Center for Health Policy is committed to engagement with the policy community. Please take our five minute survey to tell us how we are doing.
|
|
The authors examined outcomes for ACOs over time using the first four years of MSSP performance data (2013 through 2016) linked to ACO data from Leavitt Partners with the goal of answering two questions: what are patterns and causes of ACO quality measure change over time? And how did ACOs change their spending patterns across different sites of care over time, and did those changes improve their savings rate?
|
|
The federal government thought that the adoption of certified electronic health record systems (EHR) would help reduce administrative costs for physicians in a variety of specialties. However, a major new study conducted by researchers at Duke University and Harvard Business School and published in the Feb. 20, 2018, issue of the
Journal of the American Medical Association
finds that this benefit has not been achieved.
Read More
|
|
The way physicians, hospitals, and other health care professionals are paid influences patient care because payment methods affect business models that clinicians and health care facilities use to prioritize investments, establish infrastructure, and design care processes. Fee-for-service medicine and its volume-based financial incentives can lead to overuse of low-value services and suboptimal care. A consensus is emerging among patients, health care professionals, payers, and purchasers that transitioning to alternative payment models (APMs) that better incentivize value for patients is essential for improving the quality and affordability of health care. Read more in a Viewpoint co-authored by
Mark McClellan, MD, PhD,
in JAMA.
|
|
A number of Duke-Margolis faculty and staff presented at the
AcademyHealth National Health Policy Conference
in Washington, DC.
David Anderson, MS,
and
Charlene Wong, MD, MSPH,
organized a
panel entitled “State of the evidence on consumer decision support tools for heath plan choice”.
Allison Kratka (mentors
Peter Ubel, MD,
and Charlene Wong) also presented at the conference on “How hard is it to be an informed healthcare consumer?” David Anderson also presented a poster,
“Evolving Insurer Business Strategies on the Individual Marketplace”.
|
|
This public workshop, convened under a cooperative agreement with the Food and Drug Administration, is being held in response to public comments received on the draft guidance “
Safety Assessment for IND Safety Reporting” issued in December 2015 requesting a public meeting to discuss the draft guidance and its implications. Broadly, this workshop will provide an opportunity for the stakeholder community to continue discussions around key challenges related to IND reporting practices proposed in the guidance. Sessions will highlight industry experience implementing these approaches, and discussion topics will include but not limited to safety assessment and aggregate analysis, as well as potential best practices for unblinding of data and trial integrity, identifying expected/anticipated events, and determining reporting thresholds.
Learn More and Register
|
|
Convened by the Duke-Robert J. Margolis, MD, Center for Health Policy at Duke University and supported by a cooperative agreement with FDA, this public event will bring the stakeholder community together to discuss the challenges that rare disease settings pose for treatment development and regulatory decision-making, as well as the promising study designs and analytical methods that can help overcome them.
The day’s discussion will center around novel approaches to trial design and analysis to improve efficiency and interpretability of results in rare disease trials.
Learn More and Register
|
|
We are pleased to extend a special invitation for you to be our guest at a live* event produced by NEJM Catalyst and hosted by the Duke Clinical Research Institute and the Duke-Margolis Center for Health Policy: Patient Behavior Change: Building Blocks for Success. This event, which will be streamed live to an international audience, will feature a phenomenal slate of healthcare leaders and researchers who will share insights on the keys to creating and sustaining behavior change for health.
Learn More and Register
|
|
Convened by the Duke-Robert J. Margolis, MD, Center for Health Policy at Duke University and supported by a cooperative agreement with FDA, this public event will bring the stakeholder community together to discuss a variety of topics related to eligibility criteria in clinical trials, their potential impact on patient access to investigational drugs, and how they might facilitate the enrollment of a diverse patient population.
Other topics that will be addressed during the public meeting include alternative clinical trial designs that may increase enrollment of more diverse patient populations, as well as opportunities for using data from expanded access trials.
Learn More and Register
|
|
The Duke-Margolis Center for Health Policy's mission is to improve health and the value of health care by developing and implementing evidence-based policy solutions locally, nationally, and globally.
|
|
This newsletter is published monthly by the Robert J. Margolis, MD, Center for Health Policy at Duke University.
|
|
|
|
|
|
|
